NCT04820647Completed
KF STRIDE to Improve Job Interview Skills
A Strength-Based Intervention to Improve Job Interview Skills in Young Adults
Source: ClinicalTrials.gov · Last updated 20 Mar 2024
Brief summary (registry, in English)
The goals of the current study are to evaluate the preliminary effectiveness and feasibility of Kessler Foundation-Strength Identification and Expression (KF-STRIDE) in an 8-week randomized controlled trial comparing the intervention to services as usual (SAU).
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 40 (actual)
- First submitted
- 25 Mar 2021
- Start date
- 29 Mar 2021
- Primary completion date
- 12 Jan 2024
- Lead sponsor
- Kessler Foundation
- Diseases
- Autism
- NCT number
- NCT04820647
What you commit to
- Study type: Interventional
- Participants enrolled: 40
- From 29 Mar 2021 to the primary completion date, 12 Jan 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- History of stroke, Traumatic Brain Injury, or neurological injury or disease in the past (like brain tumor or epilepsy).
- History of significant psychiatric illness
- Uncontrolled seizures or other unstable medical complications.
Who the study is looking for
- adolescents with Autism Spectrum Disorder
- Live in the United States of America
- Ages of 14-26
- Speak English fluently and at a 4th grade reading level
Age in the registry: 14 years to 26 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Kessler Foundation Coordinator of this site? Confirm its status | East Hanover | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.